Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Nivolumab

Type I diabetes mellitus: case report

    • 5 Accesses

    This is a preview of subscription content, log in to check access.

    Reference

    1. Hatakeyama Y, et al. Nivolumab-induced acute-onset type 1 diabetes mellitus as an immune-related adverse event: A case report. Journal of Oncology Pharmacy Practice 25: 2023-2026, No. 8, Dec 2019. Available from: URL: http://doi.org/10.1177/1078155218816777

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Nivolumab. Reactions Weekly 1791, 201 (2020). https://doi.org/10.1007/s40278-020-75046-6

    Download citation